Determining the Optimal Timing for Initiation of Adjuvant Chemotherapy after Resection for Stage II and III Colon Cancer

Diseases of the Colon and Rectum

Volumn 59, Issue 2, 2016, Pages 87-93

  Sun, Zhifei ^a   Adam, Mohamed A ^a   Kim, Jina ^a   Nussbaum, Daniel P ^a   Benrashid, Ehsan ^a   Mantyh, Christopher R ^a   Migaly, John ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adjuvant chemotherapy; Colon cancer; Optimal timing; Outcomes

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COLON CANCER; COLON RESECTION; CONFERENCE PAPER; FEMALE; FOLLOW UP; HEMICOLECTOMY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; RETROSPECTIVE STUDY; TOTAL COLON RESECTION; TREATMENT OUTCOME; ADJUVANT CHEMOTHERAPY; COLONIC NEOPLASMS; MIDDLE AGED; MORTALITY; PATHOLOGY; PATIENT SELECTION; POSTOPERATIVE PERIOD; PROCEDURES; SURVIVAL ANALYSIS; TIME FACTOR;

AGED; CHEMOTHERAPY, ADJUVANT; COLECTOMY; COLONIC NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PATIENT SELECTION; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84954439857     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1097/DCR.0000000000000518     Document Type: Conference Paper

References (27)

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5-29.
2. L aurie JA, Moertel CG, Fleming TR, et al. Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic. J Clin Oncol. 1989;7:1447-1456.
3. Moertel CG, Fleming TR, Macdonald JS, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med. 1990;322:352-358.
4. Benson AB 3rd, Bekaii-Saab T, Chan E, et al; National Comprehensive Cancer Network. Localized colon cancer, version 3.2013: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw. 2013;11:519-528.
5. Benson AB 3rd, Schrag D, Somerfield MR, et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol. 2004;22:3408-3419.
6. Figueredo A, Charette ML, Maroun J, Brouwers MC, Zuraw L. Adjuvant therapy for stage II colon cancer: a systematic review from the Cancer Care Ontario Program in evidence-based care's gastrointestinal cancer disease site group. J Clin Oncol. 2004;22:3395-3407.
7. A ndré T, Boni C, Navarro M, et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol. 2009;27:3109-3116.
8. Czaykowski PM, Gill S, Kennecke HF, Gordon VL, Turner D. Adjuvant chemotherapy for stage III colon cancer: does timing matter Dis Colon Rectum. 2011;54:1082-1089.
9. Hershman D, Hall MJ, Wang X, et al. Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer. Cancer. 2006;107:2581-2588.
10. Yothers G, O'Connell MJ, Allegra CJ, et al. Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analyses. J Clin Oncol. 2011;29:3768-3774.
11. Biagi JJ, Raphael MJ, Mackillop WJ, Kong W, King WD, Booth CM. Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis. JAMA. 2011;305:2335-2342.
12. Yu S, Shabihkhani M, Yang D, et al. Timeliness of adjuvant chemotherapy for stage III adenocarcinoma of the colon: a measure of quality of care. Clin Colorectal Cancer. 2013;12:275-279.
13. Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med. 1989;8:551-561.
14. Contal C, O'Quigley J. An application of changepoint methods in studying the effect of age on survival in breast cancer. Comput Stat Data An. 1999;30:253-70.
15. Desquilbet L, Mariotti F. Dose-response analyses using restricted cubic spline functions in public health research. Stat Med. 2010;29:1037-1057.
16. Bilimoria KY, Ko CY, Tomlinson JS, et al. Wait times for cancer surgery in the United States: trends and predictors of delays. Ann Surg. 2011;253:779-785.
17. Des Guetz G, Nicolas P, Perret GY, Morere JF, Uzzan B. Does delaying adjuvant chemotherapy after curative surgery for colorectal cancer impair survival A meta-analysis. Eur J Cancer. 2010;46:1049-1055.
18. Bayraktar UD, Chen E, Bayraktar S, et al. Does delay of adjuvant chemotherapy impact survival in patients with resected stage II and III colon adenocarcinoma Cancer. 2011;117:2364-2370.
19. Berglund A, Cedermark B, Glimelius B. Is it deleterious to delay the start of adjuvant chemotherapy in colon cancer stage III Ann Oncol. 2008;19:400-402.
20. Cheung WY, Neville BA, Earle CC. Etiology of delays in the initiation of adjuvant chemotherapy and their impact on outcomes for Stage II and III rectal cancer. Dis Colon Rectum. 2009;52:1054-1064.
21. Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, Bouvier AM. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg. 2006;244:254-259.
22. Goldie JH, Coldman AJ. A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep. 1979;63:1727-1733.
23. Hensler T, Hecker H, Heeg K, et al. Distinct mechanisms of immunosuppression as a consequence of major surgery. Infect Immun. 1997;65:2283-2291.
24. Park SK, Brody JI, Wallace HA, Blakemore WS. Immunosuppressive effect of surgery. Lancet. 1971;1:53-55.
25. Gill S, Loprinzi CL, Sargent DJ, et al. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much J Clin Oncol. 2004;22:1797-1806.
26. Wasserman DW, Boulos M, Hopman WM, Booth CM, Goodwin R, Biagi JJ. Reasons for delay in time to initiation of adjuvant chemotherapy for colon cancer (published online ahead of print August 19, 2014). J Oncol Pract. doi: 10.1200/JOP.2014.001531.
27. Zheng Z, Jemal A, Lin CC, Hu CY, Chang GJ. Comparative effectiveness of laparoscopy vs open colectomy among nonmetastatic colon cancer patients: an analysis using the National Cancer Data Base (published online ahead of print February 6, 2015). J Natl Cancer Inst. doi: 10.1093/jnci/dju491.